Radiation/Nuclear Medical Countermeasure (MCM) Product Development Support
Full Description
To provide facilities, expertise and capabilities to advance the development of radiation/nuclear medical countermeasures (MCMs) for the mitigation or treatment of acute radiation syndromes/treatment of delayed effects of acute radiation exposure (ARS/DEARE), treatment of internal radionuclide contamination, and support for NIAID's bio dosimetry efforts. The contract will support research and development of radiation and nuclear medical countermeasures towards approval, licensure, or clearance. The supported work will encompass studies performed in the drug development pathway as well as the administrative foundation necessary to facilitate and coordinate these activities in partnership with NIAID. NIAID anticipates that products selected by the government for screening, testing, and development will come from industry, academia (including the NIAID- funded Centers for Medical Countermeasures against Radiation Consortium), and government agencies.
Grant Number: 75N93020D00011-0-759302400001-1
NIH Institute/Center: NIH
Principal Investigator: POLLY CHANG
Sign up free to get the apply link, save to pipeline, and set email alerts.
Sign up free →Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click